Angiotensin II activation of cyclin D1-dependent kinase activity

被引:127
作者
Watanabe, G
Lee, RJ
Albanese, C
Rainey, WE
Batlle, D
Pestell, RG
机构
[1] NORTHWESTERN UNIV, SCH MED, DIV ENDOCRINOL METAB & MOL MED, CHICAGO, IL 60611 USA
[2] NORTHWESTERN UNIV, SCH MED, DEPT MED, DIV NEPHROL & HYPERTENS, CHICAGO, IL 60611 USA
[3] UNIV TEXAS, SW MED CTR, DEPT OBSTET GYNECOL, DALLAS, TX 75235 USA
[4] UNIV TEXAS, SW MED CTR, DEPT BIOCHEM, DALLAS, TX 75235 USA
关键词
D O I
10.1074/jbc.271.37.22570
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Angiotensin II (AII) binds to specific G protein-coupled receptors and is mitogenic in adrenal, liver epithelial, and vascular smooth muscle cells. Since the cyclin D1 gene encodes the regulatory subunit of the cyclin D1-dependent kinase (CD1K) required for phosphorylation of the retinoblastoma protein (pRB), an essential and rate-limiting step in G(1) phase progression of the cell cycle, we examined the effect of AII. on cyclin D1 expression and CD1K activity in the human adrenal cell line H295R. AII (10(-6) M) stimulated G(1) phase progression within 12 h, with a maximal effect after 72 h. This action was antedated by the induction of cyclin D1 mRNA (3-fold), cyclin D1 nuclear protein abundance (4-fold), and CD1K activity (4-fold). AT(1) induced cyclin D1 promoter activity 4-fold, via the AT(1) receptor through an enhancer sequence at -954 base pairs. c-Fos and c-Jun bound the cyclin D1 -954 enhancer sequence, and the abundance of c-Fos within this complex was increased by All treatment, AII induced extracellular signal-regulated kinase (ERK) activity 7-fold, and dominant-negative mutants of either p21(ras) or ERK reduced AII stimulated cyclin D1 promoter activity. These findings suggest that AII may stimulate mitogenesis by increasing CD1K activity through a p21(ras)/ERK/activator protein 1 pathway.
引用
收藏
页码:22570 / 22577
页数:8
相关论文
共 73 条
  • [1] TRANSFORMING P21(RAS) MUTANTS AND C-ETS-2 ACTIVATE THE CYCLIN D1 PROMOTER THROUGH DISTINGUISHABLE REGIONS
    ALBANESE, C
    JOHNSON, J
    WATANABE, G
    EKLUND, N
    VU, D
    ARNOLD, A
    PESTELL, RG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (40) : 23589 - 23597
  • [2] 12-O-TETRADECANOYL-PHORBOL-13-ACETATE INDUCTION OF THE HUMAN COLLAGENASE GENE IS MEDIATED BY AN INDUCIBLE ENHANCER ELEMENT LOCATED IN THE 5'-FLANKING REGION
    ANGEL, P
    BAUMANN, I
    STEIN, B
    DELIUS, H
    RAHMSDORF, HJ
    HERRLICH, P
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (06) : 2256 - 2266
  • [3] ROLE OF CALCIUM IN ANGIOTENSIN II-MEDIATED ALDOSTERONE SECRETION
    BARRETT, PQ
    BOLLAG, WB
    ISALES, CM
    MCCARTHY, RT
    RASMUSSEN, H
    [J]. ENDOCRINE REVIEWS, 1989, 10 (04) : 496 - 518
  • [4] BERNSTEIN LR, 1994, J BIOL CHEM, V269, P9401
  • [5] BHAT GJ, 1994, J BIOL CHEM, V269, P31443
  • [6] HUMAN NCI-H295 ADRENOCORTICAL CARCINOMA-CELLS - A MODEL FOR ANGIOTENSIN-II-RESPONSIVE ALDOSTERONE SECRETION
    BIRD, IM
    HANLEY, NA
    WORD, RA
    MATHIS, JM
    MCCARTHY, JL
    MASON, JI
    RAINEY, WE
    [J]. ENDOCRINOLOGY, 1993, 133 (04) : 1555 - 1561
  • [7] CYCLIN D1 TRANSGENE IMPEDES LYMPHOCYTE MATURATION AND COLLABORATES IN LYMPHOMAGENESIS WITH THE MYC GENE
    BODRUG, SE
    WARNER, BJ
    BATH, ML
    LINDEMAN, GJ
    HARRIS, AW
    ADAMS, JM
    [J]. EMBO JOURNAL, 1994, 13 (09) : 2124 - 2130
  • [8] EFFECTS OF ANGIOTENSIN-II AND VASOPRESSIN ON HUMAN SMOOTH-MUSCLE CELLS-INVITRO
    CAMPBELLBOSWELL, M
    ROBERTSON, AL
    [J]. EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1981, 35 (02) : 265 - 276
  • [9] CAPPONI AM, 1989, ADRENAL HYPERTENSION, P45
  • [10] CYTOSTATIC GENE-THERAPY FOR VASCULAR PROLIFERATIVE DISORDERS WITH A CONSTITUTIVELY ACTIVE FORM OF THE RETINOBLASTOMA GENE-PRODUCT
    CHANG, MW
    BARR, E
    SELTZER, J
    JIANG, YQ
    NABEL, GJ
    NABEL, EG
    PARMACEK, MS
    LEIDEN, JM
    [J]. SCIENCE, 1995, 267 (5197) : 518 - 522